Skip to content
Open access

Impaired acute metabolic responses to submaximal exercise in peripheral artery disease (PAD).

Aug 2026 · Vascular Medicine · pp. 1358863X261452546 · 0 citations · 46 references
Medicine

Abstract

Background

Peripheral artery disease (PAD) is a prevalent manifestation of systemic atherosclerosis and is associated with substantial morbidity, impaired functional capacity, and adverse cardiovascular outcomes. Although reduced walking performance is a defining clinical feature of PAD, the underlying biological responses to acute physiological stress remain poorly understood.

Methods

We conducted a prospective observational study including 35 patients with PAD and 36 control participants. All participants' serum samples were collected immediately before exercise and 5 minutes after exercise. Acute metabolic responses were quantified using targeted liquid chromatography-tandem mass spectrometry. Functional assessments, between-group comparisons, and associations with disease severity were evaluated using nonparametric methods.

Results

Compared with control participants, patients with PAD exhibited distinct alterations in exercise-induced metabolic responses. Hypoxanthine showed a robust postexercise increase in controls but a blunted and directionally opposite response in PAD (p < 0.001), whereas 2-oxoglutarate increased significantly following exercise in PAD but not in controls (p < 0.001). In exploratory analyses within the PAD group, exercise-induced changes in hypoxanthine and 2-oxoglutarate were not significantly correlated with ankle-brachial index (ABI) or 6-minute walk distance (6MWD) in the available cases.

Conclusions

PAD is associated with impaired metabolic flexibility during acute exercise, characterized by altered purine- and tricarboxylic acid-related metabolic responses to exercise, supporting the concept that acute metabolic responses provide clinically relevant information beyond resting assessments in PAD.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.